Chief Investment Officer, Human Healthcare Technology Specialist & Board Director
Matt McNamara is passionate about commercialising promising human healthcare technologies.
His business acumen combined with a strong background in the life sciences sector makes him one of the industry’s most credible investment voices.
Currently, Matt continues to invest in and commercialise great healthcare technologies through an exciting portfolio of executive/non-executive board and advisory roles.
Previously, Matt spent over 30 years in the healthcare and medical sciences sector, with more than 20 years as a venture capitalist. He spent fourteen years as CIO at BioScience Managers (4 funds. $200M FUM. >20% IRR), and was previously CEO of SciCapital pre-seed fund. Prior to that he served as SVP Business Development for eBioinformatics Inc.
Early in his career, Matt spent over a decade in the Pharma industry working in sales and marketing with Merck & Co. and in general management at Johnson and Johnson Medical Pty Ltd.
Matt has a BSc (Hons) in Molecular Biology, an MBA, and is a GAICD.